Sector portfolio · VC firm · South Korea
IMM Investment's Biotech portfolio
IMM Investment has backed 13 Biotech startups in rounds we track, $485M between them, shown by the stage each has reached. The best-funded is Gi Innovation.
Funding by segment
- Stage not reported$78M5
- Series C and later$177M3
- Series B$47M3
- Series A$183M2
Where they are based
- South Korea8$349M
- United States2$81M
- Hong Kong SAR China1$31M
- India1$11M
South Korea
United States
Hong Kong SAR China
IndiaFounded
2 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M3
- $10M to $50M7
- $50M to $250M3
- $250M to $1B0
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
11 of 13 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- South Korea8
- United States2
- Hong Kong SAR China1
- India1
Startups by country, 4 countries in all.
Segment by segment
Stage not reported
5 startups · $78M raised
- KKobiolabsHong Kong SAR China$31M
ABL BioABL Bio is a biotech research company that focuses on the development of therapeutic drugs for immuno-oncology diseases.South Korea$18M
AbClonAbClon Inc.South Korea$15M
Pinot BioPinot Bio is a biotechnology company that specializes in developing new generation anticancer treatments.South Korea$9.5M
APRINOIA TherapeuticsBiotechnology, NeuorscienceUnited States$4.4M
Series C and later
3 startups · $177M raised
GI InnovationGI Innovation is a global leader of microbiome drug development.South Korea$143M- SBSpark BiopharmaSpark Biopharma is a biotechnology companySouth Korea$21M
Inventera PharmaceuticalsInventera Pharmaceutical is a biotechnology company that specializes in the development of imaging diagnostic contrast agents.-$13M
Series B
3 startups · $47M raised
SCAI TherapeuticsSCAI Therapeutics is a drug delivery platform bio-venture company for pharmaceutical industry.South Korea$28MNGeneBioNGeneBio provides in vitro diagnostics panel and clinical analysis software.India$11M
ExoStemTechExoStemTech is a biotechnology company that develops stem cell exosome therapeutics, plant exosomes, and anti-cancer drugs.South Korea$8.6M
Series A
2 startups · $183M raised
- OTOrum TherapeuticsSouth Korea$106M
OncorusOncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.United States$77M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names IMM Investment as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like IMM Investment?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.